Replies to post #29908 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

Anatabloc is about to be bypassed by isomyosmine as MYMD Pharmaceuticals will soon begin a phase 2 FDA study testing it against Hashimoto's Thyroiditis. Should the test be a success, which is very likely, Jonnie will have blown the roof off of the pharmaceutical industry as it will mean he has tamed the ever elusive untreatable immune system diseases.

MYMD has previously announced that it is preparing 4 "preclinical studies focused on additional age-related diseases, virtually all autoimmune diseases, Alzheimer's disease, various cancers and heart disease'.

[Value_Investor]

Wow, Gap-Up at 0.0013 x 0.0020! What happened today? RCPIQ is up 30% so far! I bet some very good news will be released very soon...

Anyway the current 52-week-high 0.0024 will be easily broken up once we start to slap the cheap shares at the asks --- just a few millions shares Slapping volumes should drive this hidden gem back to the Penny Land again...

RCPIQ is much much cheaper than its "Q" peers (such as BIOAQ, CERPQ, and XNNHQ etc.)!

To match the same market value with its peer BIOAQ, RCPIQ will create a New 52-week high $0.0676 which is 67.6 Times of its current 98.52% Giant discount price $0.0010!

[Value_Investor]

Well, RCPIQ is back to 0.0009 x 0.0010 now! The Key price 0.0009 might form a New bottom support in the next week since most recently over 3M shares bought at 0.0013 ~ 0.0010 from strong chart below!

Any luck to steal any 0.0009s yesterday? I noticed one MM did steal many Dirt Cheap 0.0009s without reducing the bids size at 0.0009!

Nothing above 0.0010 ask till 0.0020 from very thin asks of the Level2 except mere 10K-0.0011! So RCPIQ should easily break up its most recent New high 0.0024 with just a couple of millions shares of Slapping volumes?